Blueprint Medicines Quote - 0HOJ

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

82.54

Bid

0.00

Ask

0.00

Volume

0.00 Day's Range 0.00

82.54 52 Week Range 82.54

Market Cap

5.018B

Previous Close

82.54

Open

Last Trade

9171.19

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

504

Shares Outstanding

60,790,000

Dividend Yield

PE Ratio

-13.62

Earnings Per Share (EPS)

-8.34

Revenue

249.38M

Net Profit

-506.98M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.blueprintmedicines.com

Headquarters

Wilmington, Delaware, USA

Founded

Blueprint Medicines Corp is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0HOJ. The last closing price for Blueprint Medicines was US$82.54. Over the last year, Blueprint Medicines shares have traded in a share price range of US$ 82.54 to US$ 82.54.

Blueprint Medicines currently has 60,790,000 shares outstanding. The market capitalization of Blueprint Medicines is US$5.02 billion. Blueprint Medicines has a price to earnings ratio (PE ratio) of -13.62.

No news to show yet.

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	82.54	82.54	82.54	587	82.54	DE
4	82.54	82.54	82.54	477	82.54	DE
12	82.54	82.54	82.54	504	82.54	DE
26	82.54	82.54	82.54	290	82.54	DE
52	82.54	82.54	82.54	236	82.54	DE
156	82.54	82.54	82.54	112	82.54	DE
260	82.54	82.54	82.54	102	82.54	DE

0HOJ - Frequently Asked Questions (FAQ)

What is the current Blueprint Medicines share price?

The current share price of Blueprint Medicines is US$ 82.54

How many Blueprint Medicines shares are in issue?

Blueprint Medicines has 60,790,000 shares in issue

What is the market cap of Blueprint Medicines?

The market capitalisation of Blueprint Medicines is USD 5.02B

What is the 1 year trading range for Blueprint Medicines share price?

Blueprint Medicines has traded in the range of US$ 82.54 to US$ 82.54 during the past year

What is the PE ratio of Blueprint Medicines?

The price to earnings ratio of Blueprint Medicines is -13.62

What is the cash to sales ratio of Blueprint Medicines?

The cash to sales ratio of Blueprint Medicines is 27.68

What is the reporting currency for Blueprint Medicines?

Blueprint Medicines reports financial results in USD

What is the latest annual turnover for Blueprint Medicines?

The latest annual turnover of Blueprint Medicines is USD 249.38M

What is the latest annual profit for Blueprint Medicines?

The latest annual profit of Blueprint Medicines is USD -506.98M

What is the registered address of Blueprint Medicines?

The registered address for Blueprint Medicines is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Blueprint Medicines website address?

The website address for Blueprint Medicines is www.blueprintmedicines.com

Which industry sector does Blueprint Medicines operate in?

Blueprint Medicines operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
STAFStaffline Group Plc	24.10p (28.19%)	2.54M
VASTVast Resources Plc	0.14p (24.44%)	63.32M
CELCeladon Pharmaceuticals Plc	20.50p (24.24%)	200.2k
OMIOrosur Mining Inc	7.35p (20.49%)	9.54M
EUAEurasia Mining Plc	3.275p (15.93%)	68.11M
FXPOFerrexpo Plc	66.10p (-36.20%)	11.32M
AGTAAgriterra Ld	0.60p (-25.00%)	2.66k
SCESurface Transforms Plc	0.315p (-23.17%)	102.26M
ROQRoquefort Therapeutics Plc	2.65p (-20.90%)	13.1M
SCGLSealand Capital Galaxy Limited	5.50p (-20.29%)	10.36M
MSMNMosman Oil And Gas Limited	0.0435p (2.35%)	605.51M
INSPInspirit Energy Holdings Plc	0.0031p (10.71%)	558.71M
SYMESupply@me Capital Plc	0.003p (0.00%)	446.77M
VODVodafone Group Plc	65.24p (-6.83%)	375.45M
NTVONativo Resources Plc	0.0017p (-5.56%)	319.73M